{
    "nct_id": "NCT06428357",
    "official_title": "Efficacy of Recombinant Bovine Lactoferrin (rbLf) in Iron Regulation",
    "inclusion_criteria": "* 18-42 years\n* Body mass index less than 35 kg/m^2\n* Finger prick hemoglobin levels fitting within \"normal range\"\n\n  * Males: 14-18g/dL\n  * Females: 12-16g/dL\n* Active: meeting American College of Sports Medicine exercise guidelines or exercising more than 2 days per week of\n\n  ‚óè For females specifically:\n* Pre-menopausal: experiencing a regular period with no signs of perimenopause or menopause.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 42 Years",
    "exclusion_criteria": "* Clinically diagnosed iron-deficiency anemia, pagophagia, hemochromatosis, or other blood or iron related medical conditions.\n* Allergy or intolerance to milk, egg, soy, peanut, wheat, coconut, or almond dairy\n* Smokers or vapers of nicotine or nicotine products\n* Immunocompromised or diagnosed with Type I or II diabetes\n* Irritable Bowel Disease, Crohn's disease, Celiacs\n* Bowel movements less than three times per week, or clinically constipated\n* Oral contraceptive users that have combined iron supplementation, or non-monophasic oral contraceptive users.\n* Pregnant or nursing\n* Chronic eczema or clinically diagnosed asthma.\n* Current antibiotic use or antibiotic use within the past 6 weeks\n* If flu, corona virus, or cold occurs, subject will remain in the study with their original scheduled visits, but immune values will be excluded.\n* Vegan (due to supplement ingredients).",
    "miscellaneous_criteria": ""
}